The timing certainly is odd: US FDA Commissioner Scott Gottlieb is announcing the formal implementation of a new structure for his office will take effect March 31 – just days before he will be leaving the job April 5.
The major element of the commissioner-level restructuring is the unwinding of the “directorate” approach set up by Margaret Hamburg at...